Patents Assigned to Orquest, Inc.
-
Patent number: 6309670Abstract: A method of treatment for bone tumors comprising administering a matrix comprising collagen, a polysaccharide and a differentiation factor is provided. A polysaccharide is reacted with an oxidizing agent to open sugar rings on the polysaccharide to form aldehyde groups. The aldehyde groups are reacted to form covalent linkages to collagen.Type: GrantFiled: June 3, 1999Date of Patent: October 30, 2001Assignee: Orquest, Inc.Inventors: Mohammad Heidaran, Robert C. Spiro
-
Patent number: 6303585Abstract: A carrier and a method for preparing it are provided for use in the delivery of therapeutic agents. A polysaccharide is reacted with an oxidizing agent to open sugar rings on the polysaccharide to form aldehyde groups. The aldehyde groups are reacted to form covalent oxime linkages with a second polysaccharide and each of the first and second polysaccharide is selected from the group consisting of hyaluronic acid, dextran, dextran sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan, heparan sulfate and alginate.Type: GrantFiled: July 1, 1998Date of Patent: October 16, 2001Assignee: Orquest, Inc.Inventors: Robert C. Spiro, Andrea Y. Thompson, LinShu Liu
-
Patent number: 6288043Abstract: An injectable composition is provided for promoting bone and/or cartilage growth comprising hyaluronic acid cross-linked to sulfated polysaccharide through linking groups. The linking groups are diamines or amino polyalkylene glycols. The sulfated polysaccharide binds growth factors suitable for promoting tissue growth at the site of application of the composition.Type: GrantFiled: June 18, 1999Date of Patent: September 11, 2001Assignee: Orquest, Inc.Inventors: Robert C. Spiro, LinShu Liu
-
Publication number: 20010014664Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.Type: ApplicationFiled: April 3, 2001Publication date: August 16, 2001Applicant: Orquest, Inc., California CorporationInventor: Michael Radomsky
-
Patent number: 6221854Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10−6 to 100 mg/ml.Type: GrantFiled: July 26, 1999Date of Patent: April 24, 2001Assignee: Orquest, Inc.Inventor: Michael Radomsky
-
Patent number: 6187047Abstract: A porous three-dimensional bone grafting matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix and having a particle size of 5 microns or less.Type: GrantFiled: July 7, 1998Date of Patent: February 13, 2001Assignee: Orquest, Inc.Inventors: Michael K. Kwan, Stephen D. Pacetti, Ronald K. Yamamoto
-
Patent number: 5972385Abstract: A matrix and a method for preparing it are provided to support the growth of tissue, such as bone, cartilage or soft tissue. A polysaccharide is reacted with an oxidizing agent to open sugar rings on the polysaccharide to form aldehyde groups. The aldehyde groups are reacted to form covalent linkages to collagen.Type: GrantFiled: January 15, 1998Date of Patent: October 26, 1999Assignee: Orquest, Inc.Inventors: LinShu Liu, Robert Spiro
-
Patent number: 5942499Abstract: A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at the site of desired bone growth for a period of time sufficient to promote the bone growth. Preferably hyaluronic acid is used in a composition range of 0.1-4% by weight and preferred growth factor is bFGF, present in a concentration range of about 10.sup.-6 to 100 mg/ml.Type: GrantFiled: March 5, 1997Date of Patent: August 24, 1999Assignee: Orquest, Inc.Inventor: Michael Radomsky
-
Patent number: 5866165Abstract: A matrix and a method for preparing it are provided to support the growth of bone or cartilage tissue. A polysaccharide is reacted with an oxidizing agent to open sugar rings on the polysaccharide to form aldehyde groups. The aldehyde groups are reacted to form covalent linkages to collagen.Type: GrantFiled: January 15, 1997Date of Patent: February 2, 1999Assignee: Orquest, Inc.Inventors: LinShu Liu, Robert C. Spiro
-
Patent number: 5776193Abstract: A porous three-dimensional bone grafting matrix is provided which is biodegradable. The matrix is preferably formed from mineralized collagen where the mineral comprises particulate calcium phosphate immobilized in the matrix and having a particle size of 5 microns or less.Type: GrantFiled: April 17, 1996Date of Patent: July 7, 1998Assignee: Orquest, Inc.Inventors: Michael K. Kwan, Stephen D. Pacetti, Ronald K. Yamamoto